Lexicon Pharmaceuticals
Price & Volume
Stats
See more52W Range | $0.48-$1.84 |
Market Cap | $728.7M |
Shares Short | 22M |
Financials
See moreRevenue (12 Mos) | $49.8M |
Revenue Growth (YoY) | -79.3% |
Gross Profit (12 Mos) | $43.2M |
Diluted EPS | -$0.14 |
News
See moreYahoo Finance • 22 days ago
Novo Nordisk (CPSE:NOVO B) Valuation Check As LX9851 Expands Its Obesity Drug Pipeline
Yahoo Finance • 23 days ago
Lexicon Pharmaceuticals and Novo Nordisk Announce initiation of Phase 1 study with oral obesity drug candidate LX9851
Yahoo Finance • last month
Lexicon Pharmaceuticals Reports Fourth Quarter 2025 Financial Results and Provides Clinical Updates
About
CEO | Dr. Michael S. Exton Ph.D. |
CFO | Mr. Scott M. Coiante |
Address | 2445 Technology Forest Boulevard, The Woodlands, TX, United States, 77381 |
Sector | Healthcare |
Industry | Biotechnology |
Full-Time Employees | 81 |
